| scholarly article | Q13442814 |
| P2093 | author name string | Kim T Mueser | |
| Brandon A Gaudiano | |||
| Ivan W Miller | |||
| Jennifer E Johnson | |||
| Gary Epstein-Lubow | |||
| Carter H Davis | |||
| P2860 | cites work | The Economic Burden of Schizophrenia in the United States in 2002 | Q22241103 |
| Cognitive Behavioral Therapy for Schizophrenia | Q22251197 | ||
| Supportive therapy for schizophrenia | Q24186517 | ||
| “Mini-mental state” | Q25938989 | ||
| Acceptance and commitment therapy and contextual behavioral science: examining the progress of a distinctive model of behavioral and cognitive therapy | Q27022000 | ||
| Cost of relapse in schizophrenia | Q41008145 | ||
| Assessment of client/patient satisfaction: development of a general scale | Q41652347 | ||
| Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses | Q41875383 | ||
| Inpatient psychiatric care in the 21st century: the need for reform | Q42688508 | ||
| Improving acute psychiatric hospital services according to inpatient experiences. A user-led piece of research as a means to empowerment | Q43516013 | ||
| A historical perspective on the role of state hospitals viewed from the era of the "revolving door" | Q43695939 | ||
| The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome | Q44276631 | ||
| Predicting engagement with services for psychosis: insight, symptoms and recovery style | Q44299948 | ||
| Understanding the relationships between self-esteem, experiential avoidance, and paranoia: structural equation modelling and experience sampling studies | Q44508054 | ||
| Rehospitalization rates of newly diagnosed schizophrenic patients on atypical neuroleptic medication | Q45167091 | ||
| Training in and implementation of Acceptance and Commitment Therapy for depression in the Veterans Health Administration: therapist and patient outcomes | Q45329389 | ||
| The global costs of schizophrenia | Q46217034 | ||
| The relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trials. | Q46670479 | ||
| Perfectionism, cognitive bias, and hopelessness as prospective predictors of suicidal ideation | Q47343287 | ||
| Adopting the perspective of another in belief attribution: contribution of Relational Frame Theory to the understanding of impairments in schizophrenia | Q47419042 | ||
| Development of an abbreviated schizophrenia quality of life scale using a new method | Q48015505 | ||
| Reasoning, emotions, and delusional conviction in psychosis. | Q48340636 | ||
| Preliminary psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. | Q50603729 | ||
| Responding mindfully to distressing psychosis: A grounded theory analysis. | Q50631946 | ||
| Life hassles, experiential avoidance and distressing delusional experiences. | Q50639996 | ||
| Risk factors for suicide in patients with schizophrenia: nested case-control study. | Q50923529 | ||
| Experiential avoidance as a generalized psychological vulnerability: comparisons with coping and emotion regulation strategies. | Q50951655 | ||
| Acute treatment of inpatients with psychotic symptoms using Acceptance and Commitment Therapy: pilot results. | Q50969530 | ||
| The use of acceptance and commitment therapy to prevent the rehospitalization of psychotic patients: a randomized controlled trial. | Q51037594 | ||
| World Health Organisation Disability Assessment Schedule II: contribution to the Italian validation. | Q51872611 | ||
| Six-month outcome following a relapse of schizophrenia. | Q51986526 | ||
| Unmasking a cognitive vulnerability to depression: how lapses in mental control reveal depressive thinking. | Q51987949 | ||
| Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms. | Q52006654 | ||
| The Role of Experiential Avoidance in Posttraumatic Stress Symptoms and Symptoms of Depression, Anxiety, and Somatization | Q57669265 | ||
| Unlinking Negative Cognition and Symptoms of Depression: Evidence of a Specific Treatment Effect for Cognitive Therapy | Q60152949 | ||
| Cognitive predictors of symptom return following depression treatment | Q60152957 | ||
| The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder | Q61480061 | ||
| Inpatient unit for combined physical and psychiatric disorders | Q70022095 | ||
| The Impact of Discharge Planning on Chronic Schizophrenic Patients | Q70197088 | ||
| Course of treatment response in first-episode and chronic schizophrenia | Q70996304 | ||
| Psychiatric patients' attitudes about medication and factors affecting noncompliance | Q73264379 | ||
| Defining 'response' in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs | Q79744901 | ||
| North Wales randomized controlled trial of cognitive behaviour therapy for acute schizophrenia spectrum disorders: outcomes at 6 and 12 months | Q80352471 | ||
| Gender and schizophrenia | Q80567239 | ||
| Meta-analysis of the brief psychiatric rating scale factor structure | Q81427194 | ||
| Time course for antipsychotic treatment response in first-episode schizophrenia | Q83058853 | ||
| Schizophrenia | Q28267772 | ||
| Efficacy of the third wave of behavioral therapies: a systematic review and meta-analysis | Q28267808 | ||
| Acceptance and commitment therapy: model, processes and outcomes | Q28282845 | ||
| Mindfulness interventions for psychosis: a meta-analysis | Q28296748 | ||
| Do mindfulness-based therapies have a role in the treatment of psychosis? | Q28301767 | ||
| Acceptance and Commitment Therapy: A Meta-Analytic Review | Q29396631 | ||
| Ironic processes of mental control. | Q29543631 | ||
| The voices acceptance and action scale (VAAS): Pilot data | Q31110425 | ||
| Distribution of the product confidence limits for the indirect effect: program PRODCLIN | Q33303721 | ||
| Psychotic symptoms as a continuum between normality and pathology | Q33422179 | ||
| Measuring the costs of schizophrenia. Implications for the post-institutional era in the US. | Q33569520 | ||
| Thought suppression and psychopathology. | Q33740249 | ||
| Paradoxical and less paradoxical effects of thought suppression: a critical review | Q34093660 | ||
| Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes. | Q34151062 | ||
| Lifetime prevalence of psychotic and bipolar I disorders in a general population | Q34596831 | ||
| Illness management and recovery: a review of the research | Q34938562 | ||
| Mindfulness groups for distressing voices and paranoia: a replication and randomized feasibility trial | Q34988227 | ||
| Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature | Q34989186 | ||
| Supportive therapy for schizophrenia: possible mechanisms and implications for adjunctive psychosocial treatments | Q35791722 | ||
| Admissions to acute psychiatric inpatient services in Auckland, New Zealand: a demographic and diagnostic review. | Q36324228 | ||
| Size of treatment effects and their importance to clinical research and practice | Q36347965 | ||
| Is symptomatic improvement in clinical trials of cognitive-behavioral therapy for psychosis clinically significant? | Q36375949 | ||
| Caution regarding the use of pilot studies to guide power calculations for study proposals | Q36465222 | ||
| Coping with hallucinated voices in schizophrenia: a review of self-initiated strategies and therapeutic interventions | Q36707999 | ||
| The global burden of disease in 1990: summary results, sensitivity analysis and future directions | Q36794690 | ||
| Is it the symptom or the relation to it? Investigating potential mediators of change in acceptance and commitment therapy for psychosis | Q36904530 | ||
| Goals of inpatient treatment for psychiatric disorders | Q37253090 | ||
| The evolution of cognitive behavior therapy for schizophrenia: current practice and recent developments | Q37310224 | ||
| Mental health nurses establishing psychosocial interventions within acute inpatient settings | Q37416286 | ||
| Adapting to the challenge of psychosis: personal resilience and the use of sealing-over (avoidant) coping strategies | Q39267611 | ||
| The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia | Q39283306 | ||
| Rehospitalizations among patients in the Medicare fee-for-service program | Q39513280 | ||
| Long-term effects of brief acceptance and commitment therapy for psychosis | Q39683025 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | acceptance and commitment therapy | Q424533 |
| psychosis | Q170082 | ||
| P577 | publication date | 2017-05-05 | |
| P1433 | published in | Healthcare | Q27726790 |
| P1476 | title | Acceptance and Commitment Therapy for Inpatients with Psychosis (the REACH Study): Protocol for Treatment Development and Pilot Testing | |
| P478 | volume | 5 |
Search more.